Moderna, Inc. (MRNA)
231.35
-17.34
(-6.97%)
USD |
NASDAQ |
Nov 12, 16:00
231.50
+0.15
(+0.06%)
After-Hours: 06:22
Moderna Price to Book Value : 13.67 for Nov. 12, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 13.67 |
| November 11, 2026 | 14.70 |
| November 10, 2026 | 14.82 |
| November 09, 2026 | 15.90 |
| November 06, 2026 | 15.02 |
| November 05, 2026 | 14.27 |
| November 04, 2026 | 15.27 |
| November 03, 2026 | 13.50 |
| November 02, 2026 | 13.05 |
| October 30, 2026 | 13.10 |
| October 29, 2026 | 13.16 |
| October 28, 2026 | 12.66 |
| October 27, 2026 | 12.29 |
| October 26, 2026 | 11.75 |
| October 23, 2026 | 11.82 |
| October 22, 2026 | 11.97 |
| October 21, 2026 | 14.52 |
| October 20, 2026 | 14.30 |
| October 19, 2026 | 13.41 |
| October 16, 2026 | 12.88 |
| October 15, 2026 | 13.97 |
| October 14, 2026 | 13.37 |
| October 13, 2026 | 12.78 |
| October 12, 2026 | 12.63 |
| October 09, 2026 | 13.30 |
| Date | Value |
|---|---|
| October 08, 2026 | 11.64 |
| October 07, 2026 | 11.61 |
| October 06, 2026 | 11.08 |
| October 05, 2026 | 12.01 |
| October 02, 2026 | 11.23 |
| October 01, 2026 | 11.16 |
| September 30, 2026 | 11.38 |
| September 29, 2026 | 12.01 |
| September 28, 2026 | 11.64 |
| September 25, 2026 | 11.74 |
| September 24, 2026 | 11.50 |
| September 23, 2026 | 10.75 |
| September 22, 2026 | 10.77 |
| September 21, 2026 | 10.21 |
| September 18, 2026 | 9.091 |
| September 17, 2026 | 9.328 |
| September 16, 2026 | 8.594 |
| September 15, 2026 | 8.485 |
| September 14, 2026 | 8.657 |
| September 11, 2026 | 8.496 |
| September 10, 2026 | 8.063 |
| September 09, 2026 | 8.003 |
| September 08, 2026 | 8.282 |
| September 04, 2026 | 8.590 |
| September 03, 2026 | 8.786 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Revolution Medicines, Inc. | 15.88 |
| Vaxcyte, Inc. | 3.88 |
| Twist Bioscience Corp. | 16.06 |
| BioNTech SE | 1.048 |
| Vir Biotechnology, Inc. | 2.292 |
Price to Book Value Related Metrics
| PS Ratio | 36.99 |
| Price | 231.35 |
| Earnings Yield | -3.07% |
| Market Cap | 93.47B |